ProductsBack/InVivoMAb anti-human MAGE-C2 (CT10)

InVivoMAb anti-human MAGE-C2 (CT10)

Name: InVivoMAb anti-human MAGE-C2 (CT10)
SKU: BE0335_B56
Availability: BackOrder

BE0335

ApplicationsImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

ReactivityHuman

Overview

Supplier
Bio X Cell
Product Name
InVivoMAb anti-human MAGE-C2 (CT10)
Delivery Days Customer
7
Applications
ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
LX-CT10.5
Concentration
4-11 mg/ml
Estimated Purity
>95%
Host
Mouse
Isotype
IgG2a
Reactivity
Human
Storage Instruction
2°C to 8°C
UNSPSC
12352203

Zeng P, Wang Y, Zheng Y, et al. Cancer‑testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cells. Mol Med Rep. 2018,17(2):3226-3231. doi: 10.3892/mmr.2017.8260
Read this paper
Curioni-Fontecedro A, Pitocco R, Schoenewolf NL, et al. Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma. Biomed Res Int. 2015,2015:432479. doi: 10.1155/2015/432479
Read this paper
Bode PK, Barghorn A, Fritzsche FR, et al. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors. Mod Pathol. 2011,24(6):829-35.
Read this paper
Zhuang R, Zhu Y, Fang L, et al. Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2. Cancer Immun. 2006,6:7.
Read this paper